ANNABELL LIESER
Papers
1
Total Citations
2
H-Index
1
About
Annabell Lieser is a clinical researcher whose work focuses on the intersection of advanced radiotherapy and metastatic disease management. Her primary research areas include stereotactic body radiotherapy (SBRT), robotic radiosurgery, and the treatment of oligometastatic disease, with a particular emphasis on lung metastases. Her major contribution lies in evaluating the efficacy and toxicity of robotic SBRT (rSBRT) for patients with limited metastatic spread—a population where local control can significantly impact survival and quality of life. Her most cited paper, "Efficacy and Toxicity of Robotic Stereotactic Body Radiotherapy of Lung Metastases in Patients With Oligometastatic Disease" (2023), investigates which clinical and treatment factors determine the success of this modern technique. This work addresses a critical gap in understanding how to optimize patient selection and treatment parameters for rSBRT. While her citation count is still growing, her research is foundational for clinicians seeking to refine non-invasive, high-precision treatments for metastatic cancer. Lieser’s work contributes to the broader shift toward personalized, metastasis-directed therapies, making her a promising voice in the field of radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1